Find out now if you have been exposed to COVID-19. The Covid Rapid Test App can tell you if your symptoms correspond to COVID-19, or if you have had a past exposure and recovered, developing temporal immunity. Antibody testing is curcial to safely end the lockdown!
Rapid diagnostics performed within 48h of the onset of symptoms can give important information to help contain COVID-19. Regular testing can help you take precautions to prevent passing the disease on to family members or coworkers. The Covid Rapid Test App helps to give you peace of mind, to manage self-isolation, and to give you certainty on when it is safe to interact with others without putting them at risk. Most importantly, the app can tell you wether you have developed temporal immunity. Find out more about the advantages of serological tests in Patel et al, 2020, and why monitoring sero conversion is important in Larremore et al, 2020.
These tests use blood, taken from your finger with a sterile lancet, to detect antibodies that develop following exposure to the COVID-19 virus. Two of the major antibodies produced in the body by the immune system's response are detected. These antibodies are detectable when the symptoms of COVID-19 appear and persist after symptoms have disappeared. Recent research from Adams et al, 2020 has shown that Lateral Flow Tests for immunity have acceptable sensitivity and specificity compared to the laboratory gold standards. Enhanced with an app reading they can substitue laboratories for massive testing.
The Covid Rapid Test App helps you interpret the results of your fingerstick blood test. It can tell you whether you have or have had a COVID-19 infection after the onset of symptoms. It also helps you track your tests over time and determine key events in the progress of the infection, if any, and if temporal immunity has been developed. Finally, it helps you protect everyone around you by knowing your status and optionally allows you to contribute to outbreak tracking and management in your area.
The Covid Rapid Test App and technology infrastructure is highly scalable and can be deployed in multiple cloud solutions. Our solution is GCP compliant and GDPR compliant. Immediate situational notifications can be sent, while preserving anonymity.
First, the tests detect the levels of IgG and IgM antibodies in blood by lateral flow immunoassay. These are produced by the body's immune response to SARS-CoV-2 infection. Second, the app takes a reading of the antibody levels from the test result lines on the test strip, the proprietary Colorimetrix® software and helps to interpret the results with semi-quantitative accuracy in order to determine the stage of COVID-19. You can read more about test specificity in Li et al, 2020 and test antigens in Lv et al, 2020.
In comparison with qPCR RNA tests, which require extensive laboratory equipment to run, antibody-based tests can be performed at the point of care, either at home, in your physician’s office while you wait, or at a specialized healthcare clinic. RNA tests are useful for screening before symptoms appear, and during active infections. Antibody-based tests, in contrast, can detect whether an exposure occurred in the past or if there is a current infection after the incubation phase, regardless of the presence of symptoms.
Keep yourself up to date on the progress of the project subscribe to our mailing list.